1,2-dihydroxy-3-(4'-isopropylphenoxy)propane | 1067243-35-9

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 1,2-dihydroxy-3-(4'-isopropylphenoxy)propane
• 英文别名: 3-(4-isopropylphenoxy)-propane-1,2-diol；3-(4-isopropylphenoxy)propane-1,2-diol；3-(4-Propan-2-ylphenoxy)propane-1,2-diol
• CAS: 1067243-35-9
• 化学式: C₁₂H₁₈O₃
• 分子量: 210.273
• InChiKey: BDSMDCWANLUBSG-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.7
• 重原子数：
  15
• 可旋转键数：
  5
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.5
• 拓扑面积：
  49.7
• 氢给体数：
  2
• 氢受体数：
  3

反应信息

• 作为产物：
  描述：

  4-异丙基苯酚 、 3-氯-1,2-丙二醇 在 sodium hydroxide 作用下， 以 乙醇 、 水 为溶剂， 反应 2.0h， 生成 1,2-dihydroxy-3-(4'-isopropylphenoxy)propane
  参考文献：
  名称：

  甘油的手性对烷基苯基醚：手性驱动的结晶，液晶和胶凝性能的合成和测试

  摘要：

  合成了一系列对映纯和外消旋对烷基苯甘油醚1a - k。开发了一种新的，灵敏的，图形的固体对映体纯和外消旋样品红外光谱比较的方法，以获得有关这些化合物的结晶类型的初步信息。为了检测手性固相组织中的细微差异，一种新的易于实施的方法是基于色谱法，该方法测量单一溶液中对映体的相对丰度，该溶液与任意（0

  DOI：

  10.1016/j.tetasy.2013.05.017

文献信息

• 화장료 또는 피부외용제, 및 프로필 페닐 에테르 유도체
  申请人：SEIWA KASEI COMPANY LIMITED 세이와 카세이 콤파니 리미티드(520100108171)

  公开号：KR20150074160A

  公开（公告）日：2015-07-01

  본 발명은 우수한 멜라닌 생성 억제 효과(미백 효과), 항균 효과를 가짐과 동시에 경시적 안정성 등이 우수하여 화장료의 원료로서 바람직하게 사용되는 화합물로서, tert-부틸기 등이 치환된 페놀기의 수산기에, 수산기 등이 치환된 프로필기가 결합된 프로필 페닐 에테르 유도체 화합물을 제공하며, 또한 상기 화합물을 유효성분으로서 함유하는 멜라닌 생성 억제제, 미백제, 항균제 및 상기 화합물을 배합하는 것을 특징으로 하는 화장료를 제공한다.

  本发明具有优异的黑色素生成抑制效果（美白效果）和抗菌效果，同时具有优异的经时稳定性，作为化妆品原料而适当地使用，提供了一种取代了叔丁基等的肽基的酰胺，以及与酰胺等取代的丙氨酸结合的丙氨酸肽醚衍生物化合物，以及包含该化合物作为有效成分的黑色素生成抑制剂、美白剂、抗菌剂，以及特指含有该化合物的化妆品。
• One-pot synthesis of aryloxypropanediols from glycerol: towards valuable chemicals from renewable sources
  作者：Ada M. Truscello、Cristian Gambarotti、Mirvana Lauria、Sergio Auricchio、Gabriella Leonardi、Suresh U. Shisodia、Attilio Citterio

  DOI：10.1039/c2gc36793a

  日期：——

  Glycerol offers an easy and green route for the synthesis of aryloxypropanediols of known pharmacological activity. Glycerol is selectively converted to aryloxypropanediols in a one-pot reaction, through in situ formed glycerol carbonate, under benign and solvent-free conditions. Catalyst and unreacted reagent can be recycled.

  甘油 为合成具有已知药理活性的芳氧基丙二醇提供了一条简便而绿色的途径。 甘油在原位生成的碳酸甘油酯中，通过一锅反应选择性地转化为芳氧基丙二醇溶剂无条件。 催化剂 未反应的试剂可以循环使用。
• [EN] 3-SUBSTITUED IMIDAZO (4, 5-B) PYRIDINES AND ANALOGS AS SIRTUIN MODULATORS<br/>[FR] PYRIDINES IMIDAZO (4, 5-B) 3-SUBSTITUÉES ET ANALOGUES UTILISÉS COMME MODULATEURS DE SIRTUINES
  申请人：SIRTRIS PHARMACEUTICALS INC

  公开号：WO2011116176A1

  公开（公告）日：2011-09-22

  Provided herein are novel sirtuin-modulating compounds and methods of use thereof. The sirtuin-modulating compounds may be used for increasing the lifespan of a cell, and treating and/or preventing a wide variety of diseases and disorders including, for example, diseases or disorders related to aging or stress, diabetes, obesity, neurodegenerative diseases, cardiovascular disease, blood clotting disorders, inflammation, cancer, and/or flushing as well as diseases or disorders that would benefit from increased mitochondrial activity. Also provided are compositions comprising a sirtuin-modulating compound in combination with another therapeutic agent.

  本文提供了一种新型调节sirtuin的化合物及其使用方法。这些调节sirtuin的化合物可用于延长细胞寿命，并治疗和/或预防各种疾病和紊乱，包括与老化或压力、糖尿病、肥胖、神经退行性疾病、心血管疾病、血液凝块紊乱、炎症、癌症和/或潮红相关的疾病或紊乱，以及那些受益于增加线粒体活性的疾病或紊乱。还提供了含有sirtuin调节化合物与另一治疗剂结合的组合物。
• [EN] IMIDAZOPYRIDINE AND RELATED ANALOGS AS SIRTUIN MODULATORS<br/>[FR] IMIDAZOPYRIDINE ET ANALOGUES LIÉS EN TANT QUE MODULATEURS DE LA SIRTUINE
  申请人：SIRTRIS PHARMACEUTICALS INC

  公开号：WO2009146358A1

  公开（公告）日：2009-12-03

  Provided herein are novel sirtuin-modulating compounds and methods of use thereof. The sirtuin-modulating compounds may be used for increasing the lifespan of a cell, and treating and/or preventing a wide variety of diseases and disorders including, for example, diseases or disorders related to aging or stress, diabetes, obesity, neurodegenerative diseases, cardiovascular disease, blood clotting disorders, inflammation, cancer, and/or flushing as well as diseases or disorders that would benefit from increased mitochondrial activity. Also provided are compositions comprising a sirtuin-modulating compound in combination with another therapeutic agent.

  本文提供了新颖的调节sirtuin的化合物及其使用方法。这些调节sirtuin的化合物可用于增加细胞的寿命，并用于治疗和/或预防各种疾病和紊乱，包括与老化或压力、糖尿病、肥胖、神经退行性疾病、心血管疾病、血液凝块紊乱、炎症、癌症、潮红以及需要增加线粒体活性的疾病或紊乱相关的疾病或紊乱。还提供了包含sirtuin调节化合物与另一种治疗剂组合的组合物。
• ISOINDOLINONE AND RELATED ANALOGS AS SIRTUIN MODULATORS
  申请人：Vu Chi B.

  公开号：US20110319411A1

  公开（公告）日：2011-12-29

  Provided herein are novel sirtuin-modulating compounds and methods of use thereof. The sirtuin-modulating compounds may be used for increasing the lifespan of a cell, and treating and/or preventing a wide variety of diseases and disorders including, for example, diseases or disorders related to aging or stress, diabetes, obesity, neurodegenerative diseases, cardiovascular disease, blood clotting disorders, inflammation, cancer, and/or flushing as well as diseases or disorders that would benefit from increased mitochondrial activity. Also provided are compositions comprising a sirtuin-modulating compound in combination with another therapeutic agent.

  本文提供了新型的调节sirtuin的化合物及其使用方法。这些sirtuin调节化合物可用于延长细胞寿命，以及治疗和/或预防各种疾病和疾病，包括与衰老或压力有关的疾病或疾病，糖尿病，肥胖症，神经退行性疾病，心血管疾病，血液凝块病，炎症，癌症和/或潮红，以及需要增加线粒体活性的疾病或疾病。还提供了包含sirtuin调节化合物与另一种治疗剂的组合物。